Presentation on chikungunya a and chikungunya vaccines
26 March 2021
If you have already had COVID-19 do you still need both doses of the vaccine? Do these vaccines protect you against infection? Do they protect us against variants? WHO’s Dr Katherine O’Brien answers these questions in Science in 5 this week.
News Release 11 april 2022
The CVIC tool is the WHO-UNICEF tool designed to assist countries in the process of planning and costing COVID-19 vaccination. The aim of this course is to demonstrate the use of the CVIC tool. The course is targeting national programme managers and personnel who have been involved in the costing, b...udgeting or financing processes of COVID-19 vaccine delivery in a country.
more
The Virtual cGMP Training Marathon for Vaccine Manufacturing: Principles into Practice took place from 12 Sep to 10 Oct 2023 to continue to provide manufacturers & regulators with a comprehensive array of topics to build understanding of current WHO & international GMP standards, technological advan...cements, industry practices and regulatory expectations specific to the vaccine manufacturing context. Some of the topics include computer system validation, data integrity, challenges in lyophilization and others. Real world examples and case studies will be used to show how to interpret current and recently new good manufacturing practices requirements from a practical point of view and to implement appropriate approaches.
more
The immunization program has been going well until a rumor begins that one child in a community far from the capital has become sick after receiving a vaccine. The rumor is becoming stronger every day and is picking up coverage on local radio.
Concerned that the rumor might make caregivers concer...ned about bringing their children for vaccination, a few frontline workers (FLWs) go to the house of the children who fell sick. They find out from the child's mother that she never thought her son was sick due to the vaccination he received. The mother agrees to speak to other caregivers during a community gathering to explain that her son's illness was not caused by his vaccination. She also responds to a few questions to reassure other caregivers about the safety and advantages of immunization.
more
Learn about the first Malaria vaccine. Who should receive this vaccine? What are the challenges of rolling out a Malaria vaccine in the midst of a pandemic? Dr Pedro Alonso explains in Science in 5 this week.
In response to the coronavirus disease 2019 (COVID-19) pandemic and the societal disruption it has brought, national governments and the international community have invested billions of dollars and immense amounts of human resources to develop a safe and effective vaccine in an unprecedented time f...rame. Vaccination against this novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), offers the possibility of significantly reducing severe morbidity and mortality and transmission when deployed alongside other public health strategies and improved therapies.
After registration you can download the book free of charge
more
Efforts driving universal coverage have recently been strengthened through implementation of the Global Vaccine Action Plan (GVAP) where cost estimates for immunization support were developed totaling US$40 billion of donor assistance by 2020. In addition to resource mobilization, there has been an ...increasing focus on improving both vaccine access and delivery systems. We track donor assistance for immunization by funding objective and channel from 1990 to 2016, and illustrate projections through 2020 to inform progress of the GVAP.
more
The Lancet, Early Online Publication, 11 July 2014
doi:10.1016/S0140-6736(14)60934-X
*Free registration is required to view this article
Lancet 2024; 403: 533–44
R21/Matrix-M was well tolerated and offered high efficacy against clinical malaria in African children. This
low-cost, high-efficacy vaccine is already licensed by several African countries, and recently received a WHO policy
recommendation and prequalification, offerin...g large-scale supply to help reduce the great burden of malaria in sub-
Saharan Africa.
more